Sarcoma, Soft tissue sarcoma
Results
Phase 3
This trial looked at a drug called pazopanib for soft tissue sarcoma that had spread (metastatic soft tissue sarcoma).
Recruitment start: 24 December 2008
Recruitment end: 1 March 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Michael Leahy
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 25 Nov 2014
CRUK internal database number: 5309